glp-1 receptor agonists effectiveness comparison Drug in Diabetes and Obesity Treatment Review of head‐to‐head comparisons of
Description
Without adequate protein intake and resistance exercise, muscle loss accelerates
The glucagon receptor component introduces a theoretical concern about bone density, as glucagon signalling has been associated with increased bone resorption in some preclinical models
Monthly prescriptions of Ozempic during this time exceeded 2 million doses a month (not including Wegovy and other sources of semaglutide).[ref] Hair loss: Anecdotal reports tie GLP-1 RAs and weight loss to hair loss after 3-6 months
However, it comes at a cost
A significant number of my patients [on GLP-1s] are no longer drinking, says Hurtado Andrade
